Material And Persistent Top-line DeclineA deliberate €55–60m sales reduction and guided ~10% decline in 2026 materially shrink the revenue base, eroding scale benefits and lengthening the timeline to restore growth. Reduced sales can pressure fixed-cost absorption and delay achievement of previously advertised FOCUS‑27 targets.
Large Impairments And Widening Net LossesSubstantial impairments and sharply widened net losses reflect failed investments and write-downs that shrink equity cushions and can constrain future investment. Recurring non-operating charges reduce reported profitability and signal execution risk in commodity segments.
CDMO Slowdown And Intensified Low-cost CompetitionA decline in CDMO activity and sustained pricing pressure from low-cost competitors weaken growth prospects in both early-stage services and commodity APIs. This structural competition can compress margins, reduce pipeline conversion rates, and force further portfolio exits or margin sacrifices.